Endo (NDOI) Other Stockholders Equity : $0 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Endo Other Stockholders Equity?

Endo's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $0 Mil.

Endo's quarterly Other Stockholders Equity increased from Apr. 2024 ($0 Mil) to Sep. 2024 ($0 Mil) but then declined from Sep. 2024 ($0 Mil) to Dec. 2024 ($0 Mil).

Endo Other Stockholders Equity Historical Data

The historical data trend for Endo's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Other Stockholders Equity Chart

Endo Annual Data

Trend

Dec22

Dec23

Dec24

Other Stockholders Equity

Endo Quarterly Data
	Jun23	Sep23	Dec23	Apr24	Sep24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial			-	-	-	-	-

Endo Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Endo Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Endo's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.